References
- Stratton MR, Alexandrov LB. The genomic landscape of cancer. Nature. 2014;508: 307–308. doi: 10.1038/508307a
- Huang S, Soto AM, Sonnenschein C. The end of the genetic paradigm of cancer. PLoS Biology. 2025;23(3): e3003052.
https://doi.org/10.1371/journal.pbio.3003052 - Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tissues. Nature Reviews Cancer. 2021;21: 239–256. doi: 10.1038/s41568-021-00335-3
- Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proceedings of the National academy of Sciences of the United States of America. 1975;72: 3585–3589. doi: 10.1073/pnas.72.9.3585
- Soto AM, Sonnenschein C. The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. Bioessays: News and Reviews in Molecular, Cellular and Developmental Biology. 2011;33: 332–340. doi: 10.1002/bies.201100025
- Whitehead AN. Process and reality. New York: Macmillan; 1929.
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144: 646–674. doi: 10.1016/j.cell.2011.02.013
- Pisco AO, Huang S. Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse. British Journal of +Cancer. 2015;112: 1725–1732. doi: 10.1038/bjc.2015.146
- Tisty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annual Review of Pathology. 2006;1: 119–150. doi: 10.1146/annurev.pathol.1.110304.100224
- Davies PCW, Lineweaver CH. Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors. Physical Biology. 2011;8: 015001. doi: 10.1088/1478-3975/8/1/015001
- de Thé H. Differentiation therapy revisited. Nature Reviews Cancer. 2018;18: 117–127. doi: 10.1038/nrc.2017.103